Tranexamic Acid Dosing for Major Joint Replacement Surgery

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 14, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Arthroplasty, Replacement, KneeArthroplasty, Replacement, Hip
Interventions
DRUG

Tranexamic acid

Participants in both groups will be given single intravenous bolus of TXA 20 mg/kg over 15 min after induction of spinal (or other regional technique) or general anesthesia as per standard of care.

Trial Locations (1)

Unknown

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER